Affiliations
AffiliationItem in Clipboard
Cost of starting colorectal cancer screening programs: results from five federally funded demonstration programsFlorence K L Tangka et al. Prev Chronic Dis. 2008 Apr.
AffiliationItem in Clipboard
AbstractIntroduction: In 2005, the Centers for Disease Control and Prevention (CDC) started a 3-year colorectal cancer screening demonstration project and funded five programs to explore the feasibility of a colorectal cancer program for the underserved U.S. population. CDC is evaluating the five programs to estimate implementation cost, identify best practices, and determine the most cost-effective approach. The objectives are to calculate start-up costs and estimate funding requirements for widespread implementation of colorectal cancer screening programs.
Methods: An instrument was developed to collect data on resource use and related costs. Costs were estimated for start-up activities, including program management, database development, creation of partnerships, public education and outreach, quality assurance and professional development, and patient support. Monetary value of in-kind contributions to start-up programs was also estimated.
Results: Start-up time ranged from 9 to 11 months for the five programs; costs ranged from $60,602 to $337,715. CDC funding and in-kind contributions were key resources for the program start-up activities. The budget category with the largest expenditure was labor, which on average accounted for 67% of start-up costs. The largest cost categories by activities were management (28%), database development (17%), administrative (17%), and quality assurance (12%). Other significant expenditures included public education and outreach (9%) and patient support (8%).
Conclusion: To our knowledge, no previous reports detail the costs to begin a colorectal cancer screening program for the underserved population. Start-up costs were significant, an important consideration in planning and budgeting. In-kind contributions were also critical in overall program funding. Start-up costs varied by the infrastructure available and the unique design of programs. These findings can inform development of organized colorectal cancer programs.
FiguresFigure 1
Approach to collection of cost…
Figure 1
Approach to collection of cost data in study of start-up costs in five…
Figure 1Approach to collection of cost data in study of start-up costs in five programs in Colorectal Cancer Screening Demonstration Program, 2005–2006.
Figure 2
Distribution of start-up costs, by…
Figure 2
Distribution of start-up costs, by budget category, in study of five programs in…
Figure 2Distribution of start-up costs, by budget category, in study of five programs in Colorectal Cancer Screening Demonstration Program, 2005–2006.
Figure3
Percentage distribution of start-up costs, by…
Figure3
Percentage distribution of start-up costs, by activity, averaged across the five programs in the…
Figure3Percentage distribution of start-up costs, by activity, averaged across the five programs in the Colorectal Cancer Screening Demonstration Program, 2005–2006. Numbers do not add up to 100% due to rounding.
Figure4
Distribution of start-up costs, by activity,…
Figure4
Distribution of start-up costs, by activity, in study of five programs in Colorectal Cancer…
Figure4Distribution of start-up costs, by activity, in study of five programs in Colorectal Cancer Screening Demonstration Program, 2005–2006.
Similar articlesSeeff LC, DeGroff A, Tangka F, Wanliss E, Major A, Nadel M, Ryerson AB, Royalty J, Gelb C, Reed E. Seeff LC, et al. Prev Chronic Dis. 2008 Apr;5(2):A64. Epub 2008 Mar 15. Prev Chronic Dis. 2008. PMID: 18341799 Free PMC article.
DeGroff A, Boehm J, Goode Green S, Holden D, Seeff LC. DeGroff A, et al. Prev Chronic Dis. 2008 Apr;5(2):A39. Epub 2008 Mar 15. Prev Chronic Dis. 2008. PMID: 18341775 Free PMC article.
Subramanian S, Tangka FK, Hoover S, Beebe MC, DeGroff A, Royalty J, Seeff LC. Subramanian S, et al. Cancer. 2013 Aug 1;119 Suppl 15(Suppl 15):2855-62. doi: 10.1002/cncr.28158. Cancer. 2013. PMID: 23868480 Free PMC article.
Verma M, Sarfaty M, Brooks D, Wender RC. Verma M, et al. CA Cancer J Clin. 2015 Nov-Dec;65(6):497-510. doi: 10.3322/caac.21295. Epub 2015 Sep 1. CA Cancer J Clin. 2015. PMID: 26331705 Review.
Tangka FKL, Subramanian S, Hoover S, Lara C, Eastman C, Glaze B, Conn ME, DeGroff A, Wong FL, Richardson LC. Tangka FKL, et al. Cancer Causes Control. 2019 Feb;30(2):169-175. doi: 10.1007/s10552-018-1109-x. Epub 2018 Dec 14. Cancer Causes Control. 2019. PMID: 30552592 Free PMC article. Review.
Lairson DR, Chung TH, Smith LG, Springston JK, Champion VL. Lairson DR, et al. Eval Program Plann. 2015 Jun;50:56-62. doi: 10.1016/j.evalprogplan.2015.01.009. Epub 2015 Feb 23. Eval Program Plann. 2015. PMID: 25749548 Free PMC article.
Tangka FKL, Subramanian S. Tangka FKL, et al. Eval Program Plann. 2017 Jun;62:64-66. doi: 10.1016/j.evalprogplan.2016.11.007. Epub 2016 Nov 24. Eval Program Plann. 2017. PMID: 28034480 Free PMC article. No abstract available.
Hoover S, Subramanian S, Tangka F. Hoover S, et al. Prev Chronic Dis. 2019 May 2;16:E54. doi: 10.5888/pcd16.180336. Prev Chronic Dis. 2019. PMID: 31050637 Free PMC article.
Rohan EA, Boehm JE, DeGroff A, Glover-Kudon R, Preissle J. Rohan EA, et al. Cancer. 2013 Aug 1;119 Suppl 15(Suppl 15):2870-83. doi: 10.1002/cncr.28162. Cancer. 2013. PMID: 23868482 Free PMC article.
Subramanian S, Tangka FKL, Hoover S, Cole-Beebe M, Joseph D, DeGroff A. Subramanian S, et al. Prev Chronic Dis. 2019 Apr 25;16:E50. doi: 10.5888/pcd16.180338. Prev Chronic Dis. 2019. PMID: 31022371 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3